BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Fapon receives IND clearance from FDA for anti-CD47 IgG4 monoclonal antibody FP-002
To read the full story,
subscribe
or
sign in
.
Immuno-oncology
Fapon receives IND clearance from FDA for anti-CD47 IgG4 monoclonal antibody FP-002
Feb. 23, 2023
Fapon Biopharma, a subsidiary of Guangdong Fapon Biotech Co. Ltd., has received IND clearance by the FDA for clinical trials of FP-002...
BioWorld Science
Cancer
Immuno-oncology
Monoclonal antibody
FDA
IND
